Author

M. S. Espindola

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. L. Coelho· 1 shared A. Mikels-Vigdal· 1 shared C. M. Hogaboam· 1 shared D. M. Habiel· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. L. Coelho

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologyFibrosisPeer-reviewedJan 1, 2023

Targeting Lysyl oxidase-like 2 in Idiopathic Pulmonary Fibrosis

M. S. Espindola, D. M. Habiel, A. L. Coelho…·C. M. Hogaboam

This study examines the role of LOXL2 in IPF using Simtuzumab, finding it enhances myofibroblast differentiation and fibrosis but shows no therapeutic efficacy.

DOI 10.35534/fibrosis.2023.10007

humanbulk RNA-seq

𝕏 PostBluesky